Navigation Links
SyntheMed Completes $4.0 Million Equity Placement
Date:10/1/2008

ISELIN, N.J., Oct. 1 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products and other surgical implants, announced today that it has completed the initial closing of a private placement in which it received $4.0 million in gross proceeds.

The transaction involved the issuance to investors of ten million units at $0.40 per unit. Each unit consists of one share of common stock and one three-year warrant entitling the holder to purchase one share of common stock at $0.50 per share. The transaction was placed through an agent with a consortium of European investors. The Company is authorized to raise an additional $2.0 million in the private placement on the same terms.

"We are very pleased with the positive response of the investors who participated in this placement," stated Robert Hickey, President and CEO. "The proceeds will allow us to advance the development of a portfolio of new anti-adhesion products and to prepare for the launch of REPEL-CV(R) Adhesion Barrier in the United States."

The securities offered in the private placement have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Adhesions

Adhesions, or scar tissue, are fibrous structures that connect tissue surfaces that are not normally joined. The presence of adhesions represents a prevalent and serious complication in secondary surgical procedures, increasing the length, cost and risk of the surgical procedure and can contribute to such post-operative complications as infertility, bowel obstruction, limited mobility and chronic pain.

About REPEL-CV

REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over the surface of the heart at the conclusion of an open-heart surgical procedur
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
2. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
3. SyntheMed Files Universal Shelf Registration
4. SyntheMed to Present at the Acumen BioFin Conference
5. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
6. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
7. SAFC Pharma Completes Large-Scale API Manufacturing Expansion in Ireland
8. Novagali Pharma Completes a EUR15 Million Fund Raising
9. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
10. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
11. Roche completes acquisition of ARIUS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye test alte...ackaging quality assurance one step closer for pha...t leak testing machine developed by Sepha for ...talled in several local and global pharma-companie...ss quality assurance and productivity improvements...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., No...s been a painful year. Not so for BodyLogicMD. Th...expert physicians specializing exclusively in medi...n the number of physicians in its network si...d is in progress to add more physician-owned cente...
(Date:11/24/2009)...release is available in German . , Whether ...rds: RFID tags (Radio Frequency Identification) ar...e. They make it possible to label objects or goods...y. The appropriate scanner can read and process th... affixed to goods under production conditions of u...
(Date:11/24/2009)..., CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNews...ed today it is acquiring the assets of Hyland Seed...tario. The addition of Hyland Seeds will further e...the company anticipates the introduction of Smart...de Tolerant Trait Technology in corn in 2012. The ...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...le Assessment of Micronuclei for Genotoxicity Test... Precise and cost-effective micronucleus analysis ...s Kit , Dorothea K. Torous Carol R. Tometsk.... Dycaico ,Stratagene , The icroFlow Micronucl...ecessary reagents and supplies to fix peripheral b...
...rmance Comparisons Between PfuTurbo and Taq DNA Po...merase is the superior choice for robust,high-fi...Frances Bai Janice Cline ,Stratagene , In thi...rbo DNA,polymerase * , and Taq DNA polymerase. ... or comparable (0- to 2-kb,targets) with PfuTurb...
...,,,, Perform insertion mutagenesis i...aman ,Stratagene , A 28-base insertion was int...ge site-directed mutagenesis kit.* The,inserti...on sites. Plasmid DNA,isolated from 9 out of 12 ...ith,all 3 restriction enzymes, as judged by gel ...
Other Biology Technology:Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats 2Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats 3Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats 4Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats 5PCR Performance Comparisons Between pfuturbo and Taq DNA,Polymerases 2PCR Performance Comparisons Between pfuturbo and Taq DNA,Polymerases 3PCR Performance Comparisons Between pfuturbo and Taq DNA,Polymerases 4Efficiently Insert Unique Restriction Sites into Plasmid Vectors 2Efficiently Insert Unique Restriction Sites into Plasmid Vectors 3
(Date:11/26/2009)...ut in eight European countries has shown that clos...pandemic could have a significant role in reducing...open access journal BMC Infectious Diseases comp...d weekends/holidays, finding that they were reduce...lt and Antwerp University, Belgium, led a team of ...
(Date:11/25/2009)... produced in the stomach, may be used to boost res...s disease, Yale School of Medicine researchers rep... Journal of Neuroscience . , Parkinson,s disease...n an area of the midbrain known as the substantia ...n. Reduced production of dopamine in late-stage P...
(Date:11/25/2009)... a lifetime, the heart pumps some 250 million lite...his, the muscle fibers of the heart have to be ext...olfgang Rottbauer, vice chair of the Department of...hairman: Prof. Dr. H. A. Katus), has discovered a ...he smallest muscular unit, the sarcomere. In coope...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Fastrack Automates Workflow For Homecare Providers 52355 1Fastrack Automates Workflow For Homecare Providers 52355 2Fastrack Automates Workflow For Homecare Providers 52355 3The MedZilla Report 3A June 2009 Employment Outlook for Biotech Pharma Health 13134 1The MedZilla Report 3A June 2009 Employment Outlook for Biotech Pharma Health 13134 2The MedZilla Report 3A June 2009 Employment Outlook for Biotech Pharma Health 13134 3Dr Jack P Gunter Assembles an Elite Cosmetic and Plastic Surgery Team in Dallas Texas 52351 1Dr Jack P Gunter Assembles an Elite Cosmetic and Plastic Surgery Team in Dallas Texas 52351 2Dr Jack P Gunter Assembles an Elite Cosmetic and Plastic Surgery Team in Dallas Texas 52351 3Dr Jack P Gunter Assembles an Elite Cosmetic and Plastic Surgery Team in Dallas Texas 52351 4
... influence a persons blood fat, or lipid levels, i...(CAD). While there is some understanding of the en... been less defined. Now, in an international colla...tutes of Health (NIH), scientists have discovered ...d to cholesterol and lipid levels. Seven of the 18...
...ment of Homeland,Security (DHS) announced today th... from international visitors arriving at Hartsfiel...d). The change is part of the,department,s upgrade...,security and facilitate legitimate travel by more...ying visitors, identities., "Biometrics have revo...
...ation (CRF) brings experts to New York City from a...l Conference on Cell Therapy for Cardiovascular Di... field, the three-day session will feature an in-d... repair and regeneration, angiogenesis and cutting..., Clinical Focus: Full-day programs for the dis...
Other Biology News:New genetic variants associated with lipid levels, risk for coronary artery disease 2New genetic variants associated with lipid levels, risk for coronary artery disease 3New genetic variants associated with lipid levels, risk for coronary artery disease 4New genetic variants associated with lipid levels, risk for coronary artery disease 5DHS Begins Collecting 10 Fingerprints From International Visitors at Hartsfield-Jackson Atlanta International Airport 2Cell Therapy for Cardiovascular Diseases 2Cell Therapy for Cardiovascular Diseases 3
Vsp I from Promega
CERTOMAT U from Sartorius AG
...for rapid, convenient, and efficient Denatured pro.../wash/elute process utilizes a spin column to make...on of proteins which were electro-eluted in their ...angers, offering high binding capacity fo all pH v...
Rabbit Anti-Bacillus anthracis (Anthrax) Spore Antigen Antibody, Unconjugated from HyTest Ltd.
Biology Products: